(Q35545019)

8 August 2017

1 reference

title

Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma (English)

1 reference

8 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

15 March 2024

author name string

Ronald E. Perrott

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512901

15 March 2024

L. Frank Glass

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512901

15 March 2024

Douglas S. Reintgen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512901

15 March 2024

Neil A. Fenske

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512901

15 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0190962203021364?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

https://api.elsevier.com/content/article/PII:S0190962203021364?httpAccept=text/plain

15 March 2024

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Journal of the American Academy of Dermatology

15 March 2024

published in

1 reference

8 August 2017

volume

49

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

567-88; quiz 589-92

1 reference

Prognostic histopathological factors in malignant melanoma

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia

15 March 2024

2

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II)

15 March 2024

3

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system

15 March 2024

4

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease

15 March 2024

5

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group

15 March 2024

7

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Technical details of intraoperative lymphatic mapping for early stage melanoma

15 March 2024

8

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

The orderly progression of melanoma nodal metastases

15 March 2024

9

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes.

15 March 2024

10

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Lymphatic drainage of skin to a sentinel lymph node in a feline model.

15 March 2024

11

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

The role of elective lymph node dissection in melanoma: rationale, results, and controversies

15 March 2024

12

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Elective lymph node dissection for melanoma

15 March 2024

14

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients

15 March 2024

15

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma

15 March 2024

16

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic

15 March 2024

17

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Prognosis of thick cutaneous melanoma

15 March 2024

18

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma

15 March 2024

19

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Clinical node-negative thick melanoma

15 March 2024

20

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

The prognosis of patients with thick primary melanomas: is regional lymph node status relevant, and does removing positive regional nodes influence outcome?

15 March 2024

21

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Inefficacy of immediate node dissection in stage 1 melanoma of the limbs

15 March 2024

23

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities

15 March 2024

24

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.

15 March 2024

25

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma.Preliminary results

15 March 2024

26

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study

15 March 2024

27

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger

15 March 2024

28

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial

15 March 2024

29

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Emerging evidence for a survival benefit associated with regional lymph node dissection for melanoma

15 March 2024

30

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma

15 March 2024

31

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Morbidity following prophylactic and therapeutic lymph node dissection for melanoma--a comparison

15 March 2024

34

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients

15 March 2024

35

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

15 March 2024

36

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Minimal-access surgery for staging of malignant melanoma

15 March 2024

37

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Intraoperative identification of sentinel lymph node in patients with malignant melanoma

15 March 2024

38

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins.

15 March 2024

39

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Optimal selective sentinel lymph node dissection in primary malignant melanoma

15 March 2024

40

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma.

15 March 2024

41

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck

15 March 2024

42

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Reliability of sentinel lymph node biopsy for staging melanoma.

15 March 2024

43

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care?

15 March 2024

44

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal gold scanning

15 March 2024

45

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Lymphatic mapping and sentinel node harvest for malignant melanoma

15 March 2024

46

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience

15 March 2024

47

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Lymphatic mapping and sentinel node biopsy in the management of high-risk melanoma

15 March 2024

48

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe

15 March 2024

50

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Gamma-probe guided localization of lymph nodes

15 March 2024

51

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Gamma-probe-guided lymph node localization in malignant melanoma

15 March 2024

52

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma.

15 March 2024

53

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?

15 March 2024

54

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

The definition of the sentinel lymph node in melanoma based on radioactive counts

15 March 2024

55

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Will the true sentinel node please stand?

15 March 2024

56

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

The "true" sentinel lymph node: in search of an operational definition of a biological phenomenon

15 March 2024

57

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer

15 March 2024

58

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Allergic reactions to isosulfan blue during sentinel node biopsy--a common event

15 March 2024

59

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Pathologic examination of the sentinel lymph node in malignant melanoma

15 March 2024

60

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma

15 March 2024

61

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma

15 March 2024

62

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma

15 March 2024

63

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Molecular staging of malignant melanoma: correlation with clinical outcome

15 March 2024

64

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients

15 March 2024

65

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.

15 March 2024

66

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of nonsentinel nodes following completion lymphadenectomy for melanoma

15 March 2024

67

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Frozen section investigation of the sentinel node in malignant melanoma and breast cancer

15 March 2024

68

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma

15 March 2024

69

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Frozen section analysis of sentinel lymph nodes in melanoma patients

15 March 2024

70

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes

15 March 2024

71

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology

15 March 2024

72

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

15 March 2024

73

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

15 March 2024

74

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase.

15 March 2024

78

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes.

15 March 2024

79

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion

15 March 2024

80

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm.

15 March 2024

81

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Lymphatic mapping and sentinel lymphadenectomy for melanoma

15 March 2024

82

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Altered lymphatic drainage following lymphadenectomy

15 March 2024

83

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Lymphatic mapping and sentinel lymphadenectomy after wide local excision of primary melanoma

15 March 2024

84

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Sentinel node biopsy before and after wide excision of the primary melanoma

15 March 2024

85

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases

15 March 2024

88

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma

15 March 2024

89

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

The predictive value of the sentinel lymph node in malignant melanomas

15 March 2024

90

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence

15 March 2024

91

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Sentinel lymphadenectomy for melanoma--is it a substitute for elective lymphadenectomy?

15 March 2024

92

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Melanoma recurrence in a previously dissected lymph node basin

15 March 2024

93

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement

15 March 2024

94

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Review of sentinel lymph node biopsy and systemic interferon for melanoma: promising but investigational modalities

15 March 2024

95

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

The argument against sentinel node biopsy for malignant melanoma

15 March 2024

96

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Sentinel Lymph Node Biopsy Has No Benefit for Patients with Primary Cutaneous Melanoma Metastatic to a Lymph Node: An Assertion Based on Comprehensive, Critical Analysis

15 March 2024

97

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Tumor vaccines: a role in preventing recurrence in melanoma?

15 March 2024

99

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma

15 March 2024

100

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial.

15 March 2024

101

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma

15 March 2024

102

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

15 March 2024

103

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.

15 March 2024

104

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801

15 March 2024

105

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas

15 March 2024

106

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma

15 March 2024

107

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients

15 March 2024

108

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Prognosis of thick cutaneous melanoma of the trunk and extremity

15 March 2024

110

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Lymphatic mapping and sentinel lymph node biopsy

15 March 2024

111

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

In support of sentinel node biopsy as a standard of care for patients with malignant melanoma

15 March 2024

112

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

Recent advances in melanoma staging and therapy

15 March 2024

113

1 reference

https://api.crossref.org/works/10.1067/S0190-9622(03)02136-4

15 March 2024

Identifiers

1 reference

8 August 2017

1 reference